
    
      A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Bioequivalence Study
      Comparing a Pellets Based Sachet Formulation of D961H 20 mg and a Commercial HPMC Capsule of
      D961H 20 mg After Repeated Oral Administration in Japanese Healthy Male Subjects
    
  